Compare MPLT & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MPLT | AMSC |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | United States | United States |
| Employees | N/A | 400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2025 | 2012 |
| Metric | MPLT | AMSC |
|---|---|---|
| Price | $7.78 | $25.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 4 |
| Target Price | $26.54 | ★ $61.75 |
| AVG Volume (30 Days) | 420.3K | ★ 669.8K |
| Earning Date | 12-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 82.39 | ★ 1806.25 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $900,000.00 |
| Revenue This Year | N/A | $22.95 |
| Revenue Next Year | N/A | $15.15 |
| P/E Ratio | ★ N/A | $143.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.85 | $24.87 |
| 52 Week High | $40.43 | $68.56 |
| Indicator | MPLT | AMSC |
|---|---|---|
| Relative Strength Index (RSI) | 22.05 | 31.00 |
| Support Level | N/A | N/A |
| Resistance Level | $20.46 | $31.93 |
| Average True Range (ATR) | 0.58 | 1.40 |
| MACD | -0.04 | -0.30 |
| Stochastic Oscillator | 11.14 | 4.46 |
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.